Ipique
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ipique, covering 2022-05-24 to 2022-05-24. Get the full timeline:
Most recent: EMA Refused: Ipique (bevacizumab) — Rotterdam Biologics B.V.
1 regulatory and trial event tracked for Ipique, covering 2022-05-24 to 2022-05-24. Get the full timeline:
Most recent: EMA Refused: Ipique (bevacizumab) — Rotterdam Biologics B.V.